Old Web
English
Sign In
Acemap
>
Paper
>
Acalabrutinib in Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): Updated Results from the Phase 1/2 ACE-CL-001 Study
Acalabrutinib in Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): Updated Results from the Phase 1/2 ACE-CL-001 Study
2019
John C. Byrd
Jennifer A. Woyach
Richard R. Furman
Peter Martin
Susan O'Brien
Jennifer R. Brown
Deborah M. Stephens
Jacqueline C. Barrientos
Stephen Devereux
Peter Hillmen
John M. Pagel
Dih-Yih Chen
Ahmed Hamdy
Raquel Izumi
Priti Patel
Min-Hui Wang
Nitin Jain
William G. Wierda
Keywords:
Acalabrutinib
Chronic lymphocytic leukemia
Immunology
Medicine
therapy naive
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]